ThinkCyte
Latest round
- Series C
Last raised
- Aug 2024
Total raised
- $69M
Investors
- 15
About ThinkCyte
, ThinkCyte, Inc. operates as a provider of advanced cell sorting and high-dimensional morphological profiling solutions using AI-based technology to biotechnology firms and life science researchers. In November 2025, ThinkCyte, Inc. The company provides a wide range of cell sorting and profiling solutions, such as VisionSort, a dual-mode AI-driven cell sorter for label-free and fluorescence-based sorting, and advanced morphological profiling. The platform supports various applications, including cell therapy research and development, drug discovery, and disease profiling. Additionally, the firm also provides services such as closed-system high-throughput cell sorting, quality control for cell manufacturing, and biomarker discovery.
Who invested in ThinkCyte
15 investors across 4 rounds
See all investors in ThinkCyte
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ThinkCyte
Who invested in ThinkCyte?
ThinkCyte has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ThinkCyte raised?
ThinkCyte has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did ThinkCyte last raise money?
ThinkCyte's most recent round on record is a Series C, in Aug 2024.
What does ThinkCyte do?
ThinkCyte is a biotechnology company.
Where is ThinkCyte headquartered?
ThinkCyte is headquartered in Tokyo, Japan.
Which VCs invest in companies like ThinkCyte?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ThinkCyte's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ThinkCyte? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.